Lotus Pharmaceutical Co.,Ltd. Environmental Analytics
Environmental and financial analysis dashboard for Lotus Pharmaceutical Co.,Ltd.. Industry: MANUFACTURING
Company Overview for Lotus Pharmaceutical Co.,Ltd.
Highlights
Showing data for FY2022
Operational Environmental Cost
$4.75m
Operational Environmental Cost Intensity
1.00%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$1.28m
Decoupling Rate (2020-2022)
-4.81%
Adjusted EBITDA
$166m
Adjusted EBITDA Margin
35%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 29.41% | 7.55% | 6.49% | ||
| 0.45% | 0.48% | 0.50% | 0.46% | |
| 20.18% | 12.18% | -53.17% | ||
| 0.46% | 0.46% | 0.50% | 0.20% | |
| $3m | $4m | $5m | $4m | |
| 24.72% | 9.82% | -23.32% | ||
| 0.91% | 0.95% | 1.00% | 0.66% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
35%
Adjusted EBIT Margin
29%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$382m | $456m | $476m | $553m | |
| 19.54% | 4.30% | 16.06% | ||
$298m | $351m | $305m | $329m | |
| 78.12% | 76.87% | 64.06% | 59.48% | |
$84m | $106m | $171m | $224m | |
| 21.88% | 23.13% | 35.94% | 40.52% | |
$58m | $78m | $141m | $184m | |
| 15.27% | 17.13% | 29.54% | 33.38% | |
| ENVIRONMENTAL COST DATA | ||||
$3m | $4m | $5m | $4m | |
| 0.91% | 0.95% | 1.00% | 0.66% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$80m | $101m | $166m | $220m | |
| 20.97% | 22.19% | 34.95% | 39.86% | |
$55m | $74m | $136m | $181m | |
| 14.36% | 16.18% | 28.54% | 32.72% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.50%
Scope 2 (% of Sales)
0.50%
Operational Environmental Cost Intensity
1.00%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Lotus Pharmaceutical Co.,Ltd. | TW | $5m | 1.00% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $12m | 49.78% | N/A | N/A |
Energy-related activities (3) | $2m | 9.39% | N/A | N/A |
Upstream transportation (4) | $3m | 10.84% | N/A | N/A |
Waste (5) | $0m | 1.12% | N/A | N/A |
Business travel (6) | $0m | 0.70% | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $2m | 8.86% | N/A | N/A |
Processing of products (10) | $0m | 0.03% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $5m | 19.28% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $25m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022